Banner | Jotup

Ellucian Leads Higher Education's Digital Transformation with Banner and Colleague SaaS

Retrieved on:

Monday, April 8, 2024

Software as a service, University, Saint John's University, Education, SAN, ERP, Software, Faculty, Student, Banner, Management

SAN ANTONIO and RESTON, Va., April 8, 2024 /PRNewswire/ -- Ellucian, the leading higher education technology solutions provider, has established itself as the unmatched Software as a Service (SaaS) leader in higher education, as it continues to accelerate transformation of the industry. More than 2,000 institutions serving 15 million+ students around the globe are leveraging Ellucian SaaS solutions. And in 2023 alone, there were 79 Ellucian SaaS ERP/SIS selections by colleges, universities and university systems, further solidifying the company's position as the preferred choice for institutions. With more than 50 years of experience exclusively serving colleges and universities, Ellucian has the expertise to deliver innovative and reliable SaaS solutions such as Banner and Colleague, designed with the agility to meet and exceed the unique and evolving needs of higher education.

Key Points:

More than 2,000 institutions serving 15 million+ students around the globe are leveraging Ellucian SaaS solutions.
And in 2023 alone, there were 79 Ellucian SaaS ERP/SIS selections by colleges, universities and university systems, further solidifying the company's position as the preferred choice for institutions.
With more than 50 years of experience exclusively serving colleges and universities, Ellucian has the expertise to deliver innovative and reliable SaaS solutions such as Banner and Colleague, designed with the agility to meet and exceed the unique and evolving needs of higher education.
Ellucian serves 2,900 customers in 50 countries with more than 2,000 institutions leveraging SaaS solutions.

Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research

Retrieved on:

Wednesday, March 13, 2024

Research, Gene silencing, George Washington, Phio Pharmaceuticals, Skin cancer, George Washington University, Merkel-cell carcinoma, Patient, Associate, Clinical trial, Safety, Banner, Melanoma, PD-1

Banner MD Anderson Cancer Center in Gilbert, Arizona

Key Points:

Banner MD Anderson Cancer Center in Gilbert, Arizona
Integrity Research Clinical Associates in Delray Beach, Florida
These sites join Centricity Research in Dublin, Ohio, which enrolled the study’s first patient in November.
The principal investigator at the George Washington University trial is Vishal Patel, M.D.
at the Banner MD Anderson Cancer Center trial site.
More information about this clinical trial is available at clinicaltrials.gov (identifier: NCT06014086 ).

Ludi, Inc. Appoints Chief Commercial Officer and VP of Provider Compensation

Retrieved on:

Tuesday, April 2, 2024

Nashville-based Ludi, Inc., the leader in provider compensation management, today announces the appointment of Tom Arena as Chief Commercial Officer and Eric Leafgreen as Vice President of Provider Compensation.

Key Points:

Nashville-based Ludi, Inc., the leader in provider compensation management, today announces the appointment of Tom Arena as Chief Commercial Officer and Eric Leafgreen as Vice President of Provider Compensation.
Leafgreen has nearly two decades of experience leading financial operations, provider integration and managing enterprise risk with provider arrangements.
He comes to Ludi from GenesisCare, an integrated oncology and multi-specialty provider network, where he was responsible for developing and negotiating provider compensation models.
Additionally, he advised on compensation plans, provider practice acquisitions and overall provider payment practices.

Regard and Banner Health Expand Partnership to Bring Clinical Automation to More Hospitals

Retrieved on:

Monday, March 18, 2024

Intelligence, Banner, Partnership, LOS, Diagnosis, EHR, EMR, Patient, Face, Banner Health, Health, Communication, CDI

LOS ANGELES, March 18, 2024 /PRNewswire/ -- Regard, an AI clinical platform within the EHR that helps clinicians diagnose medical conditions, today announced an expanded enterprise-wide partnership with Banner Health, one of the country's largest nonprofit health systems. Banner will roll out Regard's tool in a phased approach to all 33 acute-care hospitals spanning six states in the system in 2024.

Key Points:

Banner will roll out Regard's tool in a phased approach to all 33 acute-care hospitals spanning six states in the system in 2024.
Regard and Banner originally partnered in June of 2022 with a pilot at Banner Thunderbird Medical Center.
Recognizing successful adoption and performance of the pilot, Banner will implement the company's clinical automation technology.
Regard uses proprietary algorithms and artificial intelligence to generate clinical insights to improve workflows and patient care.

Actinium Announces Iomab-B Markedly Increases Long Term Survival in Patients 65 Years or Older with Active Relapsed or Refractory AML in the Phase 3 SIERRA Trial at the 2024 Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMT

Retrieved on:

Monday, February 26, 2024

Actinium, Leukemia, AML, TCT, Physician, Banner, TP53, BMT, Hematology, Society, Patient, Nuclear medicine, Survival, Transplant, Acute myeloid leukemia

NEW YORK, Feb. 26, 2024 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, reported new analyses from the positive Phase 3 SIERRA trial of Iomab-B in oral presentations at the at the 2024 Tandem Meetings | Transplantation & Cellular Therapy (TCT) Meetings of ASTCT® (American Society for Transplantation and Cellular Therapy and CIBMTR® (Center for International Blood and Marrow Transplant Research). The presentations reported unprecedented 100% access to potentially curative bone marrow transplant (BMT) and engraftment in evaluable patients with active relapsed or refractory acute myeloid leukemia (r/r AML) and improved long-term survival outcomes greater than 2 years in patients age 65 or older. Patients with r/r AML age 65 and older who also have multiple comorbidities and high-risk cytogenetics have a poor prognosis are seldom offered BMT in current practice due to poor tolerance to induction and conditioning regimens and dismal outcomes. The SIERRA results presented at TCT demonstrate Iomab-B's ability to overcome multiple high-risk features including a TP53 genetic mutation, advanced age and treatment resistant disease. The two oral presentations at this year's TCT mark a total of ten oral presentations of the SIERRA results at various leading transplant, hematology and nuclear medicine conferences in the USA and Europe.

Key Points:

The SIERRA results presented at TCT demonstrate Iomab-B's ability to overcome multiple high-risk features including a TP53 genetic mutation, advanced age and treatment resistant disease.
Patients receiving Iomab-B had significantly higher rates of complete remission as well as durable complete remission compared to the control arm.
Most importantly, Iomab-B produced improved long-term survival outcomes as only the patients receiving Iomab-B achieved 1-year and 2-year survival.
Iomab-B represents an important advancement in transplant conditioning and has the potential to address a significant unmet patient need."

Harpoon Therapeutics Presents HPN217 Phase 1 Clinical Data in Relapsed/Refractory Multiple Myeloma (RRMM) at ASH 2023 and Announces Selection of Recommended Phase 2 Dose (RP2D)

Retrieved on:

Tuesday, December 12, 2023

SOUTH SAN FRANCISCO, Calif., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immunotherapy company developing novel T cell engagers, today reported data from the Phase 1 study of HPN217 in patients with RRMM in an oral presentation at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego. Harpoon also announced the selection of 12 mg as the HPN217 RP2D.

Key Points:

Harpoon also announced the selection of 12 mg as the HPN217 RP2D.
During the trial, 97 patients with RRMM who had received at least three prior therapies were enrolled across 15 dose escalation cohorts and three expansion regimens.
As of the data cut-off of October 17, 2023, the data demonstrated:
Clinical activity across a wide dose range (2.15 mg to 24 mg).
The maximum tolerated dose (MTD) was not reached at the target dose using a step up approach.

THE BALTIMORE BANNER SELECTS BOB COHN AS CHIEF EXECUTIVE OFFICER

Retrieved on:

Tuesday, December 19, 2023

BALTIMORE, Dec. 19, 2023 /PRNewswire/ -- The Baltimore Banner today announced Bob Cohn has been named Chief Executive Officer ("CEO") of the local nonprofit news organization as it approaches its second anniversary. Cohn replaces Imtiaz Patel, who left The Banner in July.

Key Points:

BALTIMORE, Dec. 19, 2023 /PRNewswire/ -- The Baltimore Banner today announced Bob Cohn has been named Chief Executive Officer ("CEO") of the local nonprofit news organization as it approaches its second anniversary.
Cohn replaces Imtiaz Patel, who left The Banner in July.
"On behalf of our board of directors and our incredible staff, I'm thrilled to welcome Bob Cohn to The Venetoulis Institute and The Baltimore Banner as our new Chief Executive Officer," said Stewart Bainum, Chairman of the Board.
"The Banner has already emerged as an indispensable source for local news in Baltimore and surrounding Maryland, and I look forward to leading its next phase of growth," said Bob Cohn.

Florida Polytechnic University Selects Ellucian Banner SaaS to Modernize Student Experience

Retrieved on:

Wednesday, December 13, 2023

Student, Automation, University, Banner, Software as a service, Growth, Education, Management, STEM, Florida Polytechnic University

RESTON, Va. and LAKELAND, Fla., Dec. 13, 2023 /PRNewswire/ -- Ellucian, the leading higher education technology solutions provider, today announced that Florida Polytechnic University (Florida Poly), a top public STEM institution, has selected Ellucian Banner SaaS, a transformative and proven student information system, to modernize the student experience and support the institution's growth. A new Ellucian customer, Florida Poly joins more than 1,700 Ellucian customers leveraging SaaS solutions.

Key Points:

RESTON, Va. and LAKELAND, Fla., Dec. 13, 2023 /PRNewswire/ -- Ellucian , the leading higher education technology solutions provider, today announced that Florida Polytechnic University (Florida Poly), a top public STEM institution, has selected Ellucian Banner SaaS, a transformative and proven student information system, to modernize the student experience and support the institution's growth.
A new Ellucian customer, Florida Poly joins more than 1,700 Ellucian customers leveraging SaaS solutions.
The Ellucian SaaS Platform will deliver a modern and intuitive user experience for students and staff at Florida Poly.
"Florida Poly is excited to be working with Ellucian to modernize our student success automation support utilizing the Banner SaaS platform," said Michael Dieckmann, Vice President and CIO.

PriceSpider Promotes Brett Banner to Senior Vice President of Strategy as it Continues to Disrupt the Brand Commerce Space

Retrieved on:

Wednesday, November 15, 2023

Verizon Communications, Senior, Banner, Customer success, Strategy

IRVINE, Calif., Nov. 15, 2023 /PRNewswire/ -- PriceSpider, the market leader in brand commerce enablement solutions, which boasts more retailer relationships in more countries than anyone else, today announced it has promoted Brett Banner to Senior Vice President of Strategy.

Key Points:

In this new role, Banner will be leading the continued development of PriceSpider's advisory, community and advocacy programs.
Banner will play a pivotal role in brand commerce evangelism, ensuring that PriceSpider employees are well-equipped with the tools and knowledge they need to drive the company forward.
"PriceSpider has been the leader in brand commerce for decades," said Banner.
Banner joined PriceSpider in 2019 as Vice President of Global Customer Success, after four years leading a Customer Success SaaS division at Verizon Connect.

Ribbon-Cutting Ceremony Marks a New Chapter for The Banner School

Retrieved on:

Wednesday, November 8, 2023

Great hall, Banner, Heart, Banner School District, Head teacher, Multimedia, Learning, Environment, Student, Music, Commons, Parent, Tutoring, Tourism

FREDERICK, Md., Nov. 8, 2023 /PRNewswire-PRWeb/ -- The Banner School, a premier non-profit independent school for students in pre-kindergarten through 8th grade, is thrilled to announce the opening of its new Dill Avenue campus and the start of a new chapter. A ribbon cutting ceremony will take place on Thursday, November 16, 2023, to celebrate moving into the heart of downtown Frederick and its commitment to over forty years of educational excellence and innovation.

Key Points:

"The Banner School is excited to continue a 40-year tradition of educating curious, motivated global learners in Frederick.
The ceremony will feature remarks from Dr. Ann Wagner, Banner's new Head of School, and other distinguished guests, as well as a tour of the new facilities.
"The Banner School is excited to continue a 40-year tradition of educating curious, motivated global learners in Frederick.
The Banner School, through its Learning Triangle and its diverse community of learners, provides a nurturing yet challenging environment that motivates students to become responsible citizens who lead by example.